SCHEMBL7118504

SCHEMBL7118504

CC(C)C[C@H]1CN1S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
TSHR P16473 3/20 0.47
ALDH1A1 P00352 2/20 0.46
TRPA1 O75762 1/20 0.44
HTR7 P34969 2/20 0.43
HTR1A P08908 1/20 0.42
LMNA P02545 1/20 0.42
MMP2 P08253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
PKM P14618 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ELANE P08246 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7118507 1.00 MAPT (0.52) MAPTTDP1TSHRALDH1A1TRPA1
SCHEMBL7119451 0.86 ELANE (0.51) ALDH1A1LMNAMMP2L3MBTL1PKM
SCHEMBL7119448 0.86 ELANE (0.51) ALDH1A1LMNAMMP2L3MBTL1PKM
SCHEMBL7153336 0.84 L3MBTL1 (0.56) TSHRALDH1A1L3MBTL1CYP3A4CYP2C19
SCHEMBL7153332 0.84 L3MBTL1 (0.56) TSHRALDH1A1L3MBTL1CYP3A4CYP2C19
SCHEMBL7128095 0.82 HSD11B1 (0.52) ALDH1A1MMP2CYP3A4CYP2C19PKM
SCHEMBL7128097 0.82 HSD11B1 (0.52) ALDH1A1MMP2CYP3A4CYP2C19PKM
SCHEMBL2185769 0.77 CYP3A4 (0.48) MAPTTDP1TRPA1HTR7HTR1A
SCHEMBL18988641 0.77 TRPA1 (0.46) MAPTTDP1ALDH1A1TRPA1HTR7
SCHEMBL2185773 0.77 CYP3A4 (0.48) MAPTTDP1TRPA1HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030153771-A1 Large scale synthesis of optically pure aziridines LEXICON PHARMACEUTICALS, INC. 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153771-A1 Large scale synthesis of optically pure aziridines QDPR, AZI2, NISCH MAPT 4370/4885TDP1 4670/4885TSHR 2216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.